Literature DB >> 8948460

Mechanisms of NADPH oxidase activation in human neutrophils: p67phox is required for the translocation of rac 1 but not of rac 2 from cytosol to the membranes.

S Dusi1, M Donini, F Rossi.   

Abstract

NADPH oxidase is the enzyme complex responsible for the production of oxygen radicals in phagocytes. On neutrophil stimulation, the cytosolic components of NADPH oxidase, p67phox and p47phox, as well as the Ras-related G-protein rac 2, are translocated from the cytosol to cell membranes where they associate with a flavocytochrome b to form a functional complex. Besides rac 2, rac 1 G-protein is also involved in the activation of the NADPH oxidase, but, to date, it has not been documented whether it is also translocated in activated neutrophils. In this paper we show that: (a) in neutrophils stimulated with formylmethionyl-leucylphenylalanine, concanavalin A or phorbol 12-myristate 13-acetate, both rac 1 and rac 2 are translocated from cytosol to the membranes; (b) in neutrophils from a patient with a form of chronic granulomatous disease in which p67phox is absent, rac 2 and p47phox were translocated as in normal neutrophils on stimulation with the above agonists, but rac 1 failed to be translocated from the cytosol to the membranes. This is the first demonstration that, in activated neutrophils, rac 1 is translocated from the cytosol to the membranes and this translocation requires p67phox. These results, coupled with those showing that rac 2 is not translocated in activated neutrophils lacking p47phox [El Benna, Ruedi and Babior (1994) J. Biol. Chem. 269, 6729-6734], may suggest that the assembly of the cytosolic components of NADPH oxidase on the plasma membrane takes place through selective coupling of activated rac 1 and rac 2 with p67phox and p47phox respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8948460      PMCID: PMC1136820          DOI: 10.1042/bj3080991

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Ras-related GTP-binding proteins and leukocyte signal transduction.

Authors:  G M Bokoch; U G Knaus
Journal:  Curr Opin Hematol       Date:  1994-01       Impact factor: 3.284

Review 2.  The cellular functions of small GTP-binding proteins.

Authors:  A Hall
Journal:  Science       Date:  1990-08-10       Impact factor: 47.728

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Characterization of the 47-kilodalton autosomal chronic granulomatous disease protein: tissue-specific expression and transcriptional control by retinoic acid.

Authors:  A R Rodaway; C G Teahan; C M Casimir; A W Segal; D L Bentley
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

Review 5.  The role of small GTP-binding proteins in leukocyte function.

Authors:  G M Bokoch; U G Knaus
Journal:  Curr Opin Immunol       Date:  1994-02       Impact factor: 7.486

6.  p67-phox enhances the binding of p47-phox to the human neutrophil respiratory burst oxidase complex.

Authors:  D J Uhlinger; K L Taylor; J D Lambeth
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

7.  Independence with respect to Ca2+ changes of the neutrophil respiratory and secretory response to exogenous phospholipase C and possible involvement of diacylglycerol and protein kinase C.

Authors:  M Grzeskowiak; V Della Bianca; P De Togni; E Papini; F Rossi
Journal:  Biochim Biophys Acta       Date:  1985-01-18

8.  Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity.

Authors:  D Diekmann; A Abo; C Johnston; A W Segal; A Hall
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

9.  Activation of NADPH oxidase involves the dissociation of p21rac from its inhibitory GDP/GTP exchange protein (rhoGDI) followed by its translocation to the plasma membrane.

Authors:  A Abo; M R Webb; A Grogan; A W Segal
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

10.  Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558.

Authors:  P G Heyworth; J T Curnutte; W M Nauseef; B D Volpp; D W Pearson; H Rosen; R A Clark
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

View more
  6 in total

1.  Reduced oxidative tissue damage during endotoxemia in IRAK-1 deficient mice.

Authors:  Neeraj Singh; Liwu Li
Journal:  Mol Immunol       Date:  2012-02-24       Impact factor: 4.407

2.  The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.

Authors:  Pascal Guerard; Zo Rakotoniaina; Françoise Goirand; Luc Rochette; Monique Dumas; Frederic Lirussi; Marc Bardou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

3.  Mechanisms of NADPH oxidase activation: translocation of p40phox, Rac1 and Rac2 from the cytosol to the membranes in human neutrophils lacking p47phox or p67phox.

Authors:  S Dusi; M Donini; F Rossi
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

Review 4.  An update on the lipid nephrotoxicity hypothesis.

Authors:  Xiong Z Ruan; Zac Varghese; John F Moorhead
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

5.  Potent Inhibitory Effect of BJ-3105, a 6-Alkoxypyridin-3-ol Derivative, on Murine Colitis Is Mediated by Activating AMPK and Inhibiting NOX.

Authors:  Pallavi Gurung; Sadan Dahal; Prakash Chaudhary; Diwakar Guragain; Ujjwala Karmacharya; Jung-Ae Kim; Byeong-Seon Jeong
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

6.  Farnesyl pyrophosphate synthase inhibitor, ibandronate, improves endothelial function in spontaneously hypertensive rats.

Authors:  Jie Han; Dong-Mei Jiang; Yang Ye; Chang-Qing Du; Jian Yang; Shen-Jiang Hu
Journal:  Mol Med Rep       Date:  2016-03-21       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.